Thus, the ALJ had substantial evidence to find that neither test for fibromyalgia had been met. See Hills, 2018 WL 1914291, at *5 (affirming ALJ's finding that claimant's fibromyalgia was not medically determinable when “there [was] continuous evidence in the record of diagnoses of both gout and fibromyalgia, inconsistently assigning either one as primary, and a lack of test results ruling out other diagnoses that could cause Plaintiff's signs or symptoms”); Jodie C. v. Berryhill, No. 3:18-cv-1687-S, 2019 WL 3101689, at *15 (N.D. Tex. May 7, 2019), report and recommendation adopted, No. 3:18-cv-1687-S, 2019 WL 3081538 (N.D. Tex. July 15, 2019) (finding substantial evidence supporting ALJ's conclusion that a claimant's fibromyalgia was not medically determinable when the claimant was diagnosed and treated for both fibromyalgia and rheumatoid arthritis and there was no test results ruling out the claimant's spinal disorders as a cause of the symptoms). To the extent that Glass argues other evidence on the record may support medically determinable fibromyalgia, the Court may not reweigh the evidence as “conflicts in the evidence are for the Commissioner and not the courts to resolve.”